Frequency of delayed immune-related adverse events (irAEs) in hospitalized patients treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Durbin, Sienna
Zubiri, Leyre
Perlman, Katherine
Molina, Gabriel
Jacoby, Ted
Shah, Nishi
Reynolds, Kerry Lynn
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Massachusetts Gen Hosp, Div Oncol, Dept Med, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2652
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [2] Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    del Carpio, L. P.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruella, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 509 - 509
  • [3] Immune checkpoint inhibitors (ICIs) in gastrointestinal (GI) cancer: Immune-related adverse events (IRAEs) and efficacy.
    Das, Satya
    Ciombor, Kristen Keon
    Haraldsdottir, Sigurdis
    Pumpalova, Yoanna S.
    Sahin, Ibrahim Halil
    Shyr, Yu
    Chu, Shih-Kai
    Lin, Emily Pei-Ying
    Hsu, Chih-Yuan
    Goff, Laura Williams
    Cardin, Dana Backlund
    Bilen, Mehmet Asim
    Berlin, Jordan
    Wu, Christina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients
    Giommoni, Elisa
    Giorgione, Roberta
    Paderi, Agnese
    Pellegrini, Elisa
    Gambale, Elisabetta
    Marini, Andrea
    Antonuzzo, Andrea
    Marconcini, Riccardo
    Roviello, Giandomenico
    Matucci-Cerinic, Marco
    Capaccioli, David
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    [J]. IMMUNO, 2021, 1 (03): : 253 - 263
  • [5] Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors
    Ornstein, Moshe C.
    Calabrese, Cassandra
    Wood, Laura S.
    Kirchner, Elizabeth
    Profusek, Pamela
    Allman, Kimberly D.
    Martin, Allison
    Kontzias, Arstolos
    Grivas, Petros
    Garcia, Jorge A.
    Calabrese, Leonard H.
    Rini, Brian, I
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 177 - 182
  • [6] Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) to predict succeeding onset of immune-related adverse events (irAEs).
    Kizawa, Rika
    Miura, Yuji
    Oda, Yasuhiro
    Nagaoka, Yukiko
    Ozaki, Yukinori
    Kondoh, Chihiro
    Moriguchi, Shuhei
    Takahashi, Yui
    Ogawa, Kazumasa
    Tanabe-Hashimoto, Yuko
    Taniguchi, Shuichi
    Okaneya, Toshikazu
    Kishi, Akiko
    Hayashi, Nobukazu
    Kishi, Kazuma
    Takano, Toshimi
    Masuda, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors
    Angeles, Arkhjamil
    Sonke, Eric
    Thao Phuong Nguyen
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) predicts succeeding onset of immune-related adverse events (irAEs)
    Kizawa, R.
    Miura, Y.
    Oda, Y.
    Nagaoka, Y.
    Masuda, J.
    Ozaki, Y.
    Kondoh, C.
    Moriguchi, S.
    Takahashi, Y.
    Ogawa, K.
    Hashimoto, Y. Tanabe
    Taniguchi, S.
    Okaneya, T.
    Kishi, A.
    Hayashi, N.
    Takaya, H.
    Takano, T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [9] Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs).
    Vitale, Nuzzo Pier
    Pond, Gregory Russell
    Abou Alaiwi, Sarah
    Nassar, Amin
    Flippot, Ronan
    Choueiri, Toni K.
    Harshman, Lauren Christine
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Early incidence of immune-related adverse events (irAEs) predicts efficacy in patients (pts) with solid tumors treated with immune-checkpoint inhibitors (ICIs).
    Morehouse, Chris
    Abdullah, Shaad Essa
    Gao, Chen
    Dar, Mohammed M.
    Ranade, Koustubh
    Higgs, Brandon W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345